You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Role of IC officer

From: A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries

  Total No officer Officer Difference in proportion (95 % confidence) between officer and no officer P-value
IC SOPs 19 (61.3 %) 4 (33.3 %) 15 (78.9 %) 45.6 % (9.0, 71.5) 0.022
Sufficient waiting area space 28 (93.3 %) 10 (83.3 %) 18 (100 %) 16.7 % (−4.1, 42.5) 0.152
Surveillance of HCW 19 (61.3 %) 4 (33.3 %) 15 (78.9 %) 45.6 % (8.8, 72.5) 0.022
TB IC policies monitored 25 (80.6 %) 7 (58.3 %) 18 (94.7 %) 36.4 % (6.2, 63.9) 0.022
ID, Separation of patients with symptoms 22 (71 %) 7 (58.3 %) 15 (78.9 %) 20.6 % (−12.8, 52.6) 0.253
Separate sputum collection 25 (80.6 %) 7 (58.3 %) 18 (94.7 %) 36.4 % (6.0, 64.3) 0.022
Ventilation 25 (80.6 %) 7 (58.3 %) 18 (94.7 %) 36.4 % (5.9, 64.2) 0.022
PPE available 30 (96.8 %) 11 (91.7 %) 19 (100 %) 8.3 % (−8.0, 33.2) 0.387
N95 or equivalent masks 27 (87.1 %) 10 (83.3 %) 17 (89.5 %) 6.1 % (−18.3, 35.2) 0.63
Fit testing for masks 13 (43.3 %) 3 (25 %) 10 (55.6 %) 30.6 % (−6.0, 59) 0.141
  1. Number and percent of positive responses for each domain by whether a site had an IC officer present. The p-value is a comparison of the proportions between sites with IC officers and without IC officers